SYNTA PHARMACEUTICALS CORP - COM (SNTA)

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
55,134,393
Share change
-228,820
Total reported value
$146,100,883
Put/Call ratio
257%
Price per share
$2.65
Number of holders
82
Value change
-$1,059,264
Number of buys
40
Number of sells
39

Institutional Holders of SYNTA PHARMACEUTICALS CORP - COM (SNTA) as of Q4 2014

As of 31 Dec 2014, SYNTA PHARMACEUTICALS CORP - COM (SNTA) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,134,393 shares. The largest 10 holders included CAXTON CORP, FMR LLC, JENNISON ASSOCIATES LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, State Street Corp, NORTHERN TRUST CORP, BlackRock Institutional Trust Company, N.A., MILLENNIUM MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 82 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.